2invest AG

en

  • de
Toggle navigation Menu
  • About Us
    • Company Snapshot
    • Contact us
  • Investment Case
    • Analyst Reports
    • Takeover offer Kromi
    • Sparta offer
    • Spin-off Project
  • Financial Reporting
  • Events
    • Extraordinary General Meeting 2021
    • Extraordinary General Meeting 2020
    • Corporate Calendar
    • Events Calendar
    • Annual General Meeting
    • Extraordinary General Meeting 2019
  • News
    • 2020 Share Buy Back
    • Ad Hoc Releases
    • Press Releases
    • Regulatory News
  • Share Price Information
  • Corporate Governance
    • Corporate Governance Report
    • Declaration of Conformity
    • Management Board
    • Supervisory Board of 2invest AG
    • Bylaws Supervisory Board
    • Shareholder Structure
    • Prospectus
    • Articles of Association as PDF (German Language only)
    • Directors Dealings

Analyst Reports

Home > Investment Case > Analyst Reports

25 August 2020: First Berlin, Analyst Christian Orquera – Update note after H1 2020 financial results

15 July 2020: First Berlin, Analyst Christian Orquera –  “AIMING TO DISRUPT THE DNA MANUFACTURING MARKET”

In this section

  • Sparta offer

    Sparta AG published the offer document for the takeover bid…

    View
  • Spin-off Project

    4basebio AG announces process for spin-off and separate stock market…

    View
  • Takeover offer Kromi

    In a decision dated February 23, 2021, the German Federal…

    View
IR Information Service subscription
2invest AG
  • Home
  • Financial Reporting
  • News Centre
  • Share Price Information
  • Corporate Governance
  • Imprint

© 2021 2invest AG. Data Protection.

Website by 23ccc

2invest AG is the new name of Expedeon AG; its ticker symbol has changed to 2INV from EXNN.


2invest AG ist der neue Name der Expedeon AG; Das Tickersymbol wurde von EXNN auf 2INV geändert.